CUR NEURALSTEM INC, Last trading session close at 1.59
Rochester, NY 9/16/2009 04:09 AM GMT (TransWorldNews)
Small but breakthrough biotech drug maker Neuralstem, Inc. surged over 18% at times today. I watched this Hot Stock Confidential open position climb up to a gain of 39.4% over our logged entry price before I decided to do something about it.
Press release yesterday: According to the company, Neuralstem has “received notice of allowance from the United States Patent and Trademark Office (US PTO) for its patent entitled ‘Transplantation of Human Neural Cells For Treatment Of Neurodegenerative Conditions’, number 11/281,640.”
Last Trade: 1.59
Trade Time: 4:00pm ET
Day's Range: 1.27 - 1.60
52wk Range: 0.75 - 2.24
Change: Up 0.29 (22.31%)
Prev Close: 1.30
Avg Vol (3m): 103,712
Market Cap: 54.94M
TheCapitalGainsReport.com offers free alerts on stocks that are about to run. Click here to or scroll down to the bottom of this page to sign up now.
ABOUT Neuralstem, Inc.
Neuralstem, Inc., a biotechnology company, focuses on developing and commercializing human neural stem cell technology in the field of regenerative medicine primarily in the United States. The company uses its human neural stem cell technology to create biotherapeutic products for the treatment of central nervous system diseases and various neurodegenerative conditions, and for the regenerative repair of acute diseases. Its proprietary technology is also used in small-molecule drug discovery. The company has a research agreement with China Medical University & Hospital of Taiwan to prepare for a human clinical trial using human spinal cord neural stem cells to treat stroke patients. Neuralstem, Inc. was founded in 1996 and is headquartered in Rockville, Maryland.
TheCapitalGainsReport uses proprietary technologies coupled with years of experience to uncover stocks we feel have the greatest potential for breakout performance. We utilize not only software, but time tested criteria to uncover these potential winners. When these benchmarks are reached or exceeded, our subscribers are immediately notified.
This service is free and available only to subscribers. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
Disclaimer: Full disclaimer at http://www.thecapitalgainsreport.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither TheCapitalGainsReport , nor any of its affiliates are registered investment advisors or broker dealers.